We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$283B
AUM Growth
+$24.6B
Cap. Flow
+$7.48B
Cap. Flow %
2.64%
Top 10 Hldgs %
23.42%
Holding
10,541
New
1,808
Increased
3,387
Reduced
3,810
Closed
1,384

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$528M
2
BA icon
Boeing
BA
+$375M
3
GE icon
GE Aerospace
GE
+$346M
4
INTC icon
Intel
INTC
+$340M
5
UNP icon
Union Pacific
UNP
+$281M

Sector Composition

Rank Sector Weight
1 Technology 2.64%
2 Consumer Discretionary 0.99%
3 Communication Services 0.98%
4 Healthcare 0.9%
5 Industrials 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPRX
8826
DELISTED
Repros Therapeutics Inc.
RPRX
$61K ﹤0.01%
+91,976
New +$46.4K
DALN
8827
DELISTED
DallasNews
DALN
$60K ﹤0.01%
+3,149
New +$59.8K
BKEP
8828
DELISTED
Blueknight Energy Partners L.P.
BKEP
$60K ﹤0.01%
+11,679
New +$63.5K
APOPW
8829
DELISTED
Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
$60K ﹤0.01%
28,573
+8,326
+41% +$19.5K
NDRO
8830
DELISTED
Enduro Royalty Trust
NDRO
$60K ﹤0.01%
+19,317
New +$63.7K
JNP
8831
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$60K ﹤0.01%
+12,322
New +$59.9K
DWSN icon
8832
Dawson Geophysical
DWSN
$103M
$59K ﹤0.01%
+12,435
New +$57.9K
LRMR icon
8833
Larimar Therapeutics
LRMR
$433M
$59K ﹤0.01%
+1,068
New +$48.1K
BNTC icon
8834
Benitec Biopharma
BNTC
$442M
$58K ﹤0.01%
+77
New +$53.8K
CVEO icon
8835
CALL
Civeo
CVEO
$345M
$58K ﹤0.01%
1,775
+600
+51% +$16.5K
EVOK
8836
DELISTED
Evoke Pharma
EVOK
$58K ﹤0.01%
+179
New +$74.2K
TEN
8837
PUT
Tsakos Energy Navigation Ltd
TEN
$1.21B
$58K ﹤0.01%
2,960
-6,820
-70% -$147K
CCEC
8838
PUT
Capital Clean Energy Carriers
CCEC
$1.36B
$58K ﹤0.01%
+2,471
New +$58.1K
TRVN
8839
PUT
DELISTED
Trevena, Inc.
TRVN
$58K ﹤0.01%
58
-93
-62% -$101K
OIIM
8840
DELISTED
02Micro International
OIIM
$58K ﹤0.01%
+34,908
New +$62K
DS
8841
CALL
DELISTED
Drive Shack Inc.
DS
$58K ﹤0.01%
+10,400
New +$49.4K
XRM
8842
CALL
DELISTED
Xerium Technologies Inc (new)
XRM
$58K ﹤0.01%
+13,700
New +$60.2K
PDLI
8843
CALL
DELISTED
PDL BioPharma, Inc.
PDLI
$58K ﹤0.01%
21,200
-60,100
-74% -$185K
UTSI icon
8844
CALL
UTStarcom
UTSI
$22.4M
$57K ﹤0.01%
+2,525
New +$41.2K
XWEL icon
8845
XWELL
XWEL
$8.55M
$57K ﹤0.01%
35
+19
+119% +$28.2K
SCU
8846
PUT
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$57K ﹤0.01%
2,280
-1,860
-45% -$58.4K
SREV
8847
PUT
DELISTED
ServiceSource International, Inc.
SREV
$57K ﹤0.01%
+18,300
New +$58.8K
VVUS
8848
DELISTED
Vivus Inc
VVUS
$57K ﹤0.01%
11,412
-256
-2% -$1.75K
XBIT icon
8849
CALL
XBiotech
XBIT
$70.4M
$56K ﹤0.01%
14,200
-400
-3% -$1.68K
NBSE
8850
CALL
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$56K ﹤0.01%
+75
New +$29K

Similar funds

Jeff Yass's Q4 2017 Portfolio in Review

As of Q4 2017, Jeff Yass held 10,541 positions worth $283B, up 9.5% from $259B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Jeff Yass's Q4 2017 filing shows 1,808 new, 3,387 increased, 3,810 reduced and 1,384 closed positions. Its largest new stake was Union Pacific: 2,326,570 shares worth $312M. The largest sale was Amazon, an estimated $695M.

By sector, the portfolio is most concentrated in Technology at 2.6% of assets, up from 2.4% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Jeff Yass's largest Q4 2017 buy was Union Pacific: 2,326,570 shares worth $312M.
  • Jeff Yass added most to Apple in Q4 2017, an estimated $528M increase.
  • Jeff Yass's biggest Q4 2017 reduction was Amazon, cutting an estimated $695M.
  • Jeff Yass fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, selling an estimated $639M.
  • Jeff Yass's ten largest holdings make up 23% of its $283B portfolio in Q4 2017.
  • Jeff Yass opened 1,808 new positions and closed 1,384 in Q4 2017.
  • Jeff Yass's portfolio value rose 9.5% quarter-over-quarter to $283B.

Based on Susquehanna International Group's 13F filing for Q4 2017, filed 14 Feb 2018.